WHAT IS ICER AND WHY DOES IT MATTER? | BY: TERRY WILCOX
By: Terry Wilcox, Executive Director, Patients Rising What is ICER and why does it matter? I received this exact question from a patient recently. After all, the Institute for Clinical and…
ALLOWING ICER INTO MEDICARE DOES NOT ACHIEVE VALUE | BY: DONNA CRYER
By: Donna Cryer (Global Liver Institute) | Morning Consult As the foundation of the healthcare policy landscape undergoes a tectonic shift that promises to reward “value” in care rather than…
AN INTERVIEW WITH DONNA CRYER, GLOBAL LIVER INSTITUTE, ON ASSESSING THE VALUE OF TREATMENTS FOR LIVER DISEASE | BY: DAN LEONARD
By: Dan Leonard | National Pharmaceutical Council Donna Cryer, JD, a liver transplant recipient and founder, president and CEO of the Global Liver Institute, is a passionate advocate for patients. She…
CEPAC PUBLIC COMMENTS FOR OBETICHOLIC ACID | BY: DONNA CRYER, JD
By: Donna Cryer, JD; President & CEO | Global Liver Institute Good morning. Forgive me for speaking so quickly as I am mindful of the five minute time limit. I am…
CEPAC PUBLIC COMMENTS FOR OBETICHOLIC ACID | BY: TERRY WILCOX
By: Terry Wilcox, Executive Director | Patients Rising Thank you for the opportunity to speak to you today. Patients Rising is a 501c3 not-for-profit organization with funding by public donations,…
GLOBAL LIVER INSTITUTE AND OTHER ADVOCACY ORGANIZATIONS PUBLIC COMMENTS TO ICER ON OCA
Dear Dr. Pearson, We, as members of the liver community representing patients with primary biliary cholangitis (PBC), appreciate the opportunity to comment on the Institute for Clinical and Economic Review’s…
PATIENTS RISING PUBLIC COMMENTS TO ICER ON OCA | BY: TERRY WILCOX
Patients Rising is a Washington, DC-based non-profit organization with a very specific mission: we fight for access to vital therapies and services for all patients with life-threatening and chronic diseases. …